SINGAPORE -- PHARMA UPDATE NEWS SERVICE™ -- JUNE 22, 2016: The Sixth Asia Pacific Pharmaceutical and Medical Device Compliance Congress, www.AsianPharmaCongress.com, will be held September 21 - 23, 2016, at the Shangri-La Hotel in Singapore. Registrants may attend the event in person or online (live webcast and archived for 6 months).

AND FEATURING C-SUITE KEYNOTE BY

Eric Van Oppens Region President Asia & Russia at Alcon, a Novartis company, Former Head Asia Cluster, Novartis Pharma, Former Country President and CPO Head, Novartis South Korea, Singapore

AND GLOBAL CHIEF COMPLIANCE OFFICER ROUNDTABLE BY

Dante Beccaria Senior Vice President, Global Ethics & Business Integrity, Sanofi, Vice Chair, Code Committee Network, IFPMA, Paris, France Anne Nielsen, JD, LLM Senior Vice President, Chief Compliance and Ethics Officer, Bristol-Myers Squibb, New York, NY, USA Lori Queisser Senior Vice President and Global Compliance Officer, Teva Pharmaceuticals, Philadelphia, PA, USA

FEATURING PRECONFERENCE SESSIONS Compliance 101 Workshop Use of Analytics to Manage Risks and Detect Fraud PLENARY SESSIONS C-Suite Keynote Address Global Compliance Officer Roundtable Transparency International Keynote UK Serious Fraud Office Update US Securities and Exchange Commission Update The ISO 37001 Anti-Bribery Management Systems Standard Asia Pac Regional Regulatory and Enforcement Roundtable Asia Pac Compliance Code and APEC Principles Updates Optimizing the Relationship with Third Parties Best Practices in Medical Affairs Compliance Life Sciences Compliance Challenge: Moving from Cost to Value Roundtable on Creating an Ethical Culture AND MINI SUMMITS China, Hong Kong and Taiwan Compliance Roundtable India Compliance Roundtable Innovation in Compliance Patient Support Programs Compliance Issues Transactions, Partnerships and M&A Compliance Issues Asia Pac Medical Device Compliance Roundtable Promotional and Incentive Programs Compliance Issues Asia Pac Transparency and Disclosure Updates Research and Development Compliance Issues ASIA PACIFIC PHARMA CONGRESS IS

FEATURED FACULTY

Dr. Milind Antani, MBBS, LLB Partner in charge-Pharma & Healthcare Practice, Nishith Desai Associates, Mumbai, India Alexander Bedenkov, MD, PhD Asia Area Medical Director, Astra Zeneca, Former Global Medical Director, Strategic Medical Affairs, Established Products (EPD), Abbott, Singapore Craig Brooks-Rooney Head, Asia-Pacific, Costello Medical Singapore, Singapore Eric Carlson, Esq. Partner, Covington & Burling LLP, Contributing Editor, FCPA Blog, Singapore Sabrina S. K. Chan, MA, JD Executive Director, The Hong Kong Association of the Pharmaceutical Industry (HKAPI), Hong Kong Tom Chan, JD, LLM Head of Legal, Greater China, Takeda (China) Holdings Co. Ltd, Shanghai, China Chi Chen, MS Partner, Ernst & Young, Shanghai, China Eugene Chen, Esq. Partner, Beijing Office, Hogan Lovells International LLP, Shanghai, China Yoo-Kyung (Karen) Choi Japan and Korea Compliance Lead, Pfizer, Seoul, Korea Hwa-Soo Chung, Esq. Chair, Health Law Group, Kim & Chang Law Firm, Seoul, South Korea Campbell Clark, LLM Chief Ethics & Compliance Officer, Asia Pacific, Medtronic, Former General Counsel, Asia, Covidien, Singapore Adam Dryburgh LLB, Dip LP, LLM Associate, White Collar and Fraud Group, Hogan Lovells, Singapore Michael Dusseau Vice President, Compliance Operations, Allergan, Former Vice President, Compliance, Bayer, Former Divisional Compliance Officer, Merck, New York, NY, USA Marc Eigner, MS, MBA Senior Partner, Co-Founder and Head of the Technology Solutions, Polaris Solutions, New York, NY, USA Karen Eryou Senior Director, Corporate Compliance APAC, UCB Pharma, Former Co-chair, Asia Pacific Pharma Compliance Congress, Shanghai, China Giuseppe Falbo Regional Compliance Director (APAC and Russia), Alcon Laboratories, Inc., Singapore Andrew Frye, MBA Global Head, Business Unit Healthcare, Member of Group Management, DKSH, Bangkok, Thailand Mohit Grover Executive Director, Risk Consulting, Deloitte, Former Regional CIO, Astra Zeneca Asia Pacific, Singapore Andrew Ho Head of Ethics and Business Integrity, Australia and New Zealand, Sanofi, Former Compliance Associate, Novartis, Macquarie Park NSW, Australia David Hodgson Partner and Audit Advisory Global Lead, Deloitte, London, UK Ewa Holker, JD Head of Legal & Compliance, Asia Pacific, Ferring, Singapore Katsumi Kojima Head of Ethics & Business Integrity-Japan, Sanofi Japan Group, Tokyo, Japan Keith M. Korenchuk, JD, MPH Partner, Arnold & Porter LLP, Washington, DC, USA Andrew Martin Principal and Head of Corporate & Securities, Baker & McKenzie, Wong & Leow, Singapore Dinesh Moudgil, MBA Partner, Ernst & Young, Mumbai, India Alison Parkes, PhD Vice President Compliance, IRAMEA (India, Russia, Asia, Middle East, Africa), Smith & Nephew, Singapore Yee Chung Seck, Esq. Partner and Lead, Pharmaceutical and Healthcare Practices, Baker & McKenzie (Vietnam) Ltd., Ho Chi Minh City, Vietnam Carol Shi Compliance Director, Asia Area and ANZ, AstraZeneca, Singapore Sabina Sudan, LLB, LLM ECLS-Consults (Ethics / Compliance / Legal / Sustainability), Legal/International Compliance and Risk Management Professional, , Singapore and Delhi, India Belinda Tan Partner, Fraud Investigations & Dispute Resolutions, Ernst & Young, Singapore Emmanuel Vignal Partner, Fraud Investigation & Dispute Services, Ernst & Young, Shanghai, China Vivian W. Wu, LLB, LLM Partner, Baker & McKenzie, Beijing, China Qi (Aaron) Yao, MA Compliance Manager, Cordis, Former Associate Manager, Training, Communication & Partnering, Compliance, Shanghai Roche Pharmaceuticals Ltd., Shanghai, China Riza Faith Ybanez, LLB Legal and Compliance Head - Oncology Asia Pacific, South Africa, Novartis Asia Pacific Pharmaceuticals Pte Ltd, Singapore Mike Zhao Head, Compliance China, UCB Pharma, Shanghai, China

The Asia Pacific Healthcare Industry Compliance Team is an ad hoc, voluntary group of Asia Pacific pharmaceutical, medical device and other life sciences company compliance professionals and legal counsel who meet quarterly to discuss legal and compliance issues and best practices.

The International Society of Healthcare Ethics and Compliance Professionals (ETHICS) is a forum for open dialogue and exchange among Compliance and Ethics professionals in the Healthcare industry. Association's activities are developed around the four following pillars, sustained by one transverse and permanent objective: support professionals in Compliance and Ethics in Healthcare industry to develop and better manage their role and duties -- without any sort of commercial benefit for the Association or any of its members.

The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 50 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs.